300298.SZ
Sinocare, Inc.
SZSE · Healthcare · C 制造业 · CN
CNY 15.91
−0.87%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 15.60
From 52W high−25.83%
Volume3.17M
Market capCNY 8.86B
P/E (TTM)95.6x
P/S (TTM)1.8x
Div yield—
Key dataSep 18, 2026
Open
CNY 15.60
From 52W high
−25.83%
Volume
3.17M
Market cap
CNY 8.86B
ValuationView details →
P/E (Fwd)
120.2x
EV/EBITDA
34.3x
P/E (TTM)
95.6x
RSI (14)
47.4
MomentumView details →
1D Return
−0.87%
YTD Return
−8.65%
Similar companies
Latest newsMore news →
Sinocare announced it received medical device registration certificates from China's NMPA and Hunan Provincial Medical Products Administration, including a new Class III continuous glucose monitoring system (H6-15s) valid from September 4, 2026 to September 3, 2031, for glucose monitoring in diabetic patients aged 2 and above, calibration-free, with up to 15 days of use.13d agoSinocare announced that as of August 31, 2026, it had repurchased 9.1776 million shares (1.65% of total share capital) for a total of 149 million yuan through centralized bidding, and will continue its buyback plan.19d ago